Bank Norwegian AS
Bank Norwegian AS refers to the announcement on 8 March 2021. The bank has today issued two senior preferred bonds denominated in NOK and SEK with the following terms:
NOK 700 million with a 4 year tenor with a call option for the issuer after 3 years and quarterly thereafter, with a coupon equal to 3 months NIBOR + 1.45% p.a.
SEK 300 million with a 4 year tenor with a call option for the issuer after 3 years and quarterly thereafter, with a coupon equal to 3 months STIBOR + 1.40% p.a.
The settlement date for both issues is 18 March 2021. The bonds are issued under Bank Norwegian’s EMTN programme, and will be applied for listing on Oslo Stock Exchange.
SpareBank 1 Markets and Swedbank acted as joint lead managers.
Contact persons:
CFO Klara-Lise Aasen; phone +47 47 63 55 83; kaa@banknorwegian.no
Head of treasury Mats Benserud; phone +47 95 89 15 39; mbe@banknorwegian.no
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Genmab A/S18.10.2025 12:00:34 CEST | Press release
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer
F. Hoffmann-La Roche Ltd18.10.2025 07:00:00 CEST | Press release
Roche’s phase III evERA data showed giredestrant significantly improved progression-free survival in people with ER-positive advanced breast cancer
StoneX Group Inc.18.10.2025 01:12:36 CEST | Press release
StoneX Expands Wealth Management Offering for Latin American Clients
F. Hoffmann-La Roche Ltd17.10.2025 22:20:00 CEST | Press release
Roche presents new phase III pivotal data for vamikibart in uveitic macular edema (UME), a serious cause of vision loss
Eavor Technologies Inc.17.10.2025 18:00:00 CEST | Press release
Mark Fitzgerald Appointed President and Chief Executive Officer of Eavor Technologies Inc.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom